Form 4: Avanos Medical SVP Mojirade James Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
Mojirade James, SVP and General Counsel of Avanos Medical, reports disposing of shares to cover tax obligations following the vesting of restricted stock units.
Summary
- On March 6, 2025, Mojirade James, SVP and General Counsel of Avanos Medical, disposed of 1,846 shares of common stock at $15.3 per share to cover tax obligations related to the vesting of 6,712 time-based restricted share units (TRSUs) awarded on March 6, 2023.
- Additionally, James disposed of 2,785 shares of common stock at $15.3 per share to cover tax obligations related to the vesting of 10,129 time-based restricted share units (TRSUs) awarded on March 6, 2024.
- Following these transactions, James directly owns 69,017 shares of Avanos Medical common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock disposals for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | 6,712 time-based restricted share units (TRSUs) were awarded to the Reporting Person. |
| 03/06/2024 | 10,129 time-based restricted share units (TRSUs) were awarded to the Reporting Person. |
| 03/06/2025 | Vesting date of TRSUs and stock disposal for tax obligations. |
| 03/10/2025 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.